Recombinant Human TIE1, Fc-tagged
Cat.No. : | TIE1-74H |
Product Overview : | Recombinant Human Soluble TIE-1 fused with the Fc part of human IgG1 produced in baculovirus is a monomeric, glycosylated, polypeptide containing 749 amino acids and having a total molecular mass of 250 kDa. Human TIE-1/Fc monomer has a calculated molecular mass of approximately 105 kDa. As a result of glycosylation, the recombinant protein migrates as an approximately 125 kDa protein in SDS-PAGE under reducing conditions. The TIE1 Fc Chimera is purified by proprietary chromatographic techniques. |
- Specification
- Gene Information
- Related Products
Cat. No. : | TIE1-74H |
Description : | TIE-1 (tyrosine kinase with Ig and EGF homology domains 1) and TIE-2/Tek comprise a receptor tyrosine kinase (RTK) subfamily with unique structural characteristics: two immunoglobulin-like domains flanking three epidermal growth factor (EGF)-like domains and followed by three fibronectin type III-like repeats in the extracellular region and a split tyrosine kinase domain in the cytoplasmic region. These receptors are expressed primarily on endothelial and hematopoietic progenitor cells and play critical roles in angiogenesis, vasculogenesis and hematopoiesis. Human TIE-1 cDNA encodes a 1124 amino acid (aa) residue precursor protein with an 18 residue putative signal peptide, a 727 residue extracellular domain and a 354 residue cytoplasmic domain. Whereas two ligands have been described for TIE-2 [angiopoietin-1 (Ang1) and angiopoietin-2 (Ang2)], so far no ligand was found for TIE-1. |
Source : | Insect Cells |
Physical Appearance : | Sterile Filtered White lyophilized (freeze-dried) powder. |
Purity : | Greater than 90.0% as determined by: (a) Analysis by RP-HPLC. (b) Analysis by SDS-PAGE. |
Formulation : | TIE-1 Fc Chimera was lyophilized from a concentrated (1 mg/ml) sterile solution containing 1x PBS. |
Solubility : | It is recommended to reconstitute the lyophilized TIE-1 Fc Chimera in sterile water not less than 100µg/ml, which can then be further diluted to other aqueous solutions. |
Storage : | Lyophilized sTIE-1 although stable at room temperature for 3 weeks, should be stored desiccated below -18°C. Upon reconstitution TIE-1 should be stored at 4°Cbetween 2-7 days and for future use below -18°C. For long term storage it is recommended to add a carrier protein (0.1% HSA or BSA). Please prevent freeze-thaw cycles. |
Gene Name : | TIE1 tyrosine kinase with immunoglobulin-like and EGF-like domains 1 [ Homo sapiens ] |
Synonyms : | TIE1; tyrosine kinase with immunoglobulin-like and EGF-like domains 1; soluble TIE1 variant 1; soluble TIE1 variant 2; soluble TIE1 variant 3; soluble TIE1 variant 4; soluble TIE1 variant 5; receptor tyrosine kinase; tyrosine kinase with immunoglobulin and epidermal growth factor homology domains 1; EC 2.7.10.1; JTK14; TIE; Tyrosine-protein kinase receptor Tie-1; OTTHUMP00000008352 |
Gene ID : | 7075 |
mRNA Refseq : | NM_005424 |
Protein Refseq : | NP_005415 |
MIM : | 600222 |
UniProt ID : | P35590 |
Chromosome Location : | 1p34-p33 |
Function : | ATP binding; nucleotide binding; protein binding; receptor activity; transferase activity; transmembrane receptor protein tyrosine kinase activity |
Products Types
◆ Recombinant Protein | ||
TIE1-3841H | Recombinant Human TIE1 protein(Met1-Gln760), His-tagged | +Inquiry |
TIE1-1255H | Recombinant Human TIE1 Protein, His-tagged | +Inquiry |
TIE1-101HB | Recombinant Human TIE1 Protein, N-His tagged, Biotinylated | +Inquiry |
TIE1-01H | Recombinant Human TIE1 Protein, hIgG/His-tagged | +Inquiry |
TIE1-1256H | Recombinant Human TIE1 Protein, His-tagged | +Inquiry |
◆ Lysates | ||
TIE1-2034HCL | Recombinant Human TIE1 cell lysate | +Inquiry |
Related Gene
For Research Use Only. Not intended for any clinical use. No products from Creative BioMart may be resold, modified for resale or used to manufacture commercial products without prior written approval from Creative BioMart.
Inquiry
- Q&As
- Reviews
Q&As (6)
Ask a questionAt present, there is no direct way to increase the expression level of TIE1 protein, but it can be improved by regulating gene expression and providing nutritional support.
This protein can be used as a target for the development of new drugs, or as a drug carrier for the targeted delivery of drugs.
TIE1 is currently in clinical trials, including small molecule inhibitors against TIE1 and inhibitors against the TIE1 signaling pathway.
In clinical practice, the expression level of TIE1 can be detected to predict disease progression and prognosis, and to guide the choice of treatment regimen. For example, in the diagnosis and treatment of angiogenesis-related diseases, measuring the expression level of TIE1 can help doctors determine the type, stage, and prognosis of the disease, and guide the choice of treatment regimen.
TIE1 protein can shed light on the mechanisms of angiogenesis and embryonic development, as well as the pathogenesis of certain angiogenesis-related diseases. In addition, it is of great significance for the development of new drugs and treatment strategies.
Studies have shown that TIE1 protein plays an important role in the pathogenesis of certain autoimmune diseases.
Customer Reviews (3)
Write a reviewAfter repeated use, it can also maintain the stability of the performance, which makes me more confident in the experimental results.
Green and pollution-free, it can be seen that the manufacturer is very environmentally conscious.
The range of applications is breathtaking, and it can play an important role in any field.
Ask a Question for All TIE1 Products
Required fields are marked with *
My Review for All TIE1 Products
Required fields are marked with *
Inquiry Basket